Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bd772c7d8c609bbbbcd274f5cac9280c6> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bd772c7d8c609bbbbcd274f5cac9280c6 NCIT_P378 "NCI" @default.
- Bd772c7d8c609bbbbcd274f5cac9280c6 type Axiom @default.
- Bd772c7d8c609bbbbcd274f5cac9280c6 annotatedProperty IAO_0000115 @default.
- Bd772c7d8c609bbbbcd274f5cac9280c6 annotatedSource NCIT_C189208 @default.
- Bd772c7d8c609bbbbcd274f5cac9280c6 annotatedTarget "A topical gel formulation containing the macrolide sirolimus (rapamycin), with potential anti-proliferative and chemopreventive activities. Upon topical administration of sirolimus topical gel PTX-022, sirolimus migrates into the basal keratinocytes and is internalized by the affected cells. In turn, sirolimus binds to the immunophilin FK binding protein-12 (FKBP-12) and forms a sirolimus-FKBP-12 complex. This complex binds to and inhibits the activity of the serine/threonine kinase mammalian target of rapamycin (mTOR) and the mTOR-mediated signaling pathways, which reduces cellular proliferation in mTOR-overexpressing cells. Additionally, by inhibiting mTOR, PTX-022 may inhibit translation of mutant keratin mRNAs and the production of mutant keratins in cells in which mutant keratin genes dysregulate keratinocyte proliferation." @default.